Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, presents a comprehensive update on commercialisation progress for its PromarkerD test.
The update includes details on key milestones achieved for licencing and IP protection, and timelines for prototype kit manufacture and commercial sales.
